Dr. Mana Alshehri is a Senior Scientific Evaluation Expert at the Saudi Food and Drug Authority, specializing in the assessment of CMC sections, and the quality and safety of advanced cell and gene therapies. He previously worked as a scientist in cellular therapy and cancer research, focusing on developing innovative treatments for both liquid and solid tumors. His academic and industry experience spans the full spectrum from basic research to hands-on GMP manufacturing of cellular therapy products. Dr. Alshehri has held positions at leading international institutions including the Dana-Farber Cancer Institute (Harvard University), University of Rennes, University of Calgary, and University of Sheffield. He has received multiple prestigious awards, scholarships, and serves on national and international scientific committees. He holds a PhD in Cancer Biology, multiple board certifications in biologics, biosimilars, regenerative medicine, and blood and biotherapies, as well as executive training certifications from Harvard Business School.